Ticker | $ Bought |
---|---|
xencor inc | 17,093,500 |
avalo therapeutics inc | 9,147,820 |
tenax therapeutics inc | 1,174,840 |
nls pharmaceutics ltd | 728,437 |
forte biosciences inc | 667,979 |
Ticker | % Inc. |
---|---|
cidara therapeutics inc | 104 |
4d molecular therapeutics in | 88.22 |
elevation oncology inc | 28.31 |
ideaya biosciences inc | 21.31 |
axsome therapeutics inc | 9.53 |
ac immune sa | 3.65 |
Ticker | % Reduced |
---|---|
cg oncology inc | -58.87 |
ionis pharmaceuticals inc | -54.43 |
protagonist therapeutics inc | -44.26 |
revolution medicines inc | -41.84 |
mirum pharmaceuticals inc | -29.61 |
zymeworks inc | -21.5 |
kura oncology inc | -17.4 |
89bio inc | -10.00 |
Ticker | $ Sold |
---|---|
nls pharmaceutics ltd | -1,246,550 |
viracta therapeutics inc | -1,965,290 |
roivant sciences ltd | -28,987,300 |
unicycive therapeutics inc | -1,102,420 |
merus n v | -75,681,300 |
aslan pharmaceuticals ltd | -315,000 |
calliditas therapeutics ab | -29,242,500 |
janux therapeutics inc | -18,495,600 |
BVF INC/IL has about 88.1% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 88.1 |
Others | 11.9 |
BVF INC/IL has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
MID-CAP | 53.6 |
SMALL-CAP | 23.9 |
UNALLOCATED | 12.7 |
MICRO-CAP | 9.2 |
About 50.1% of the stocks held by BVF INC/IL either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
RUSSELL 2000 | 50.1 |
Others | 49.9 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
BVF INC/IL has 55 stocks in it's portfolio. About 65% of the portfolio is in top 10 stocks. FDMT proved to be the most loss making stock for the portfolio. MLTX was the most profitable stock for BVF INC/IL last quarter.
Last Reported on: 14 Nov, 2024Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
AGIO | agios pharmaceuticals inc | 1.55 | 1,190,110 | 52,876,500 | unchanged | 0.00 | ||
ALLK | allakos inc | 0.32 | 16,552,400 | 10,812,000 | unchanged | 0.00 | ||
ANNX | annexon inc | 1.21 | 7,000,000 | 41,440,000 | unchanged | 0.00 | ||
ASLN | aslan pharmaceuticals ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
AVTX | avalo therapeutics inc | 0.27 | 967,000 | 9,147,820 | new | |||
AXSM | axsome therapeutics inc | 2.75 | 1,046,000 | 94,004,000 | added | 9.53 | ||
CALT | calliditas therapeutics ab | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
CDTX | cidara therapeutics inc | 0.22 | 703,065 | 7,557,950 | added | 104 | ||
CELC | celcuity inc | 1.51 | 3,466,000 | 51,678,100 | unchanged | 0.00 | ||
CGEM | cullinan therapeutics inc | 2.82 | 5,750,680 | 96,266,400 | unchanged | 0.00 | ||
CTMX | cytomx therapeutics inc | 0.18 | 5,228,460 | 6,169,580 | unchanged | 0.00 | ||
ELDN | eledon pharmaceuticals inc | 0.46 | 6,293,280 | 15,670,300 | unchanged | 0.00 | ||
ELEV | elevation oncology inc | 0.05 | 2,966,840 | 1,779,800 | added | 28.31 | ||
EPIX | essa pharma inc | 1.55 | 8,748,630 | 53,016,700 | unchanged | 0.00 | ||
ETNB | 89bio inc | 1.48 | 6,811,630 | 50,406,100 | reduced | -10.00 | ||
FBRX | forte biosciences inc | 0.02 | 119,282 | 667,979 | new | |||
FBRX | forte biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
FDMT | 4d molecular therapeutics in | 2.34 | 7,382,640 | 79,806,400 | added | 88.22 | ||
FHTX | foghorn therapeutics inc | 1.44 | 5,302,000 | 49,361,600 | unchanged | 0.00 | ||
GLYC | glycomimetics inc | 0.05 | 9,544,260 | 1,612,980 | unchanged | 0.00 | ||